Multiple Myeloma – Sagar Lonial, MD, and Robert Figlin, MD, discuss clinical highlights from ASH 2018

Wednesday December 12, 2018

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Sagar Lonial, MD, Professor and Chair, Hematology & Medical Oncology, Chief Medical Officer, Winship Cancer Institute of Emory University, discuss ALCYONE, GRIFFIN, and maintenance therapy (TOURMALINE-MM3), and other multiple myeloma clinical studies presented at the American Society of Hematology 2018 meeting

Featured Videos

Nikhil Munshi, MD, on the association between MRD and survival outcomes in multiple myeloma

Noa Biran, MD, provides her impression of the Phase 3 ICARIA-MM study

Frederick Locke, MD, regarding the clinical evidence supporting CAR-T cell therapies in MM